申请人:GENENTECH, INC.
公开号:US10179767B2
公开(公告)日:2019-01-15
The invention provides compounds having activity as sodium channel (e.g., NaV1.7) inhibitors that are useful for treating sodium channel-mediated diseases or conditions, such as pain, as well as other diseases and conditions associated with the mediation of sodium channels, and compositions containing such compounds and methods for using such compounds and compositions.
本发明提供了具有钠通道(如 NaV1.7)抑制剂活性的化合物,这些化合物可用于治疗钠通道介导的疾病或病症,如疼痛,以及与钠通道介导相关的其他疾病和病症,还提供了含有此类化合物的组合物以及使用此类化合物和组合物的方法。